{
    "abstract": "Background Hepatitis C virus (HCV) genomic variability is a major challenge to the generation of a prophylactic vaccine. We have previously shown that HCV specific T-cell responses induced by a potent T-cell vaccine encoding a single strain subtype-1b immunogen target epitopes dominant in natural infection. However, corresponding viral regions are highly variable at a population level, with a reduction in T-cell reactivity to these variants. We therefore designed and manufactured second generation simian adenovirus vaccines encoding genomic segments, conserved between viral genotypes and assessed these for immunogenicity. Methods We developed a computer algorithm to identify HCV genomic regions that were conserved between viral subtypes. Conserved segments below a pre-defined diversity threshold spanning the entire HCV genome were combined to create novel immunogens (1000\u20131500 amino-acids), covering variation in HCV subtypes 1a and 1b, genotypes 1 and 3, and genotypes 1\u20136 inclusive. Simian adenoviral vaccine vectors (ChAdOx) encoding HCV conserved immunogens were constructed. Immunogenicity was evaluated in C57BL6 mice using panels of genotype-specific peptide pools in ex-vivo IFN-\u03d2 ELISpot and intracellular cytokine assays. Results ChAdOx1 conserved segment HCV vaccines primed high-magnitude, broad, cross-reactive T-cell responses; the mean magnitude of total HCV specific T-cell responses was 1174 SFU/106 splenocytes for ChAdOx1-GT1-6 in C57BL6 mice targeting multiple genomic regions, with mean responses of 935, 1474 and 1112 SFU/106 against genotype 1a, 1b and 3a peptide panels, respectively. Functional assays demonstrated IFNg and TNFa production by vaccine-induced CD4 and CD8 T-cells. In silico analysis shows that conserved immunogens contain multiple epitopes, with many described in natural HCV infection, predicting immunogenicity in humans. Conclusions Simian adenoviral vectored vaccines encoding genetic segments that are conserved between all major HCV genotypes contain multiple T-cell epitopes and are highly immunogenic in pre-clinical models. These studies pave the way for the assessment of multi-genotypic HCV T-cell vaccines in humans.",
    "author_highlights": [
        {
            "endOffset": 15131,
            "sentence": "This study describes HCV prophylactic vaccines designed to target multiple genotypes.",
            "startOffset": 15046
        },
        {
            "endOffset": 15214,
            "sentence": "HCV conserved immunogens were encoded within a simian adenoviral vector (ChAdOx1).",
            "startOffset": 15132
        },
        {
            "endOffset": 15303,
            "sentence": "Vaccines are highly immunogenic in mice and induce T-cells targeting multiple genotypes.",
            "startOffset": 15215
        },
        {
            "endOffset": 15390,
            "sentence": "HCV immunogens contain multiple human T-cell epitopes as defined in natural infection.",
            "startOffset": 15304
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "G. R.",
                    "initial": "G.R.",
                    "last": "Foster"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Afdhal"
                },
                {
                    "first": "S. K.",
                    "initial": "S.K.",
                    "last": "Roberts"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Br"
                },
                {
                    "first": "E. J.",
                    "initial": "E.J.",
                    "last": "Gane"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Pianko"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Lawitz"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Thompson"
                },
                {
                    "first": "M. L.",
                    "initial": "M.L.",
                    "last": "Shiffman"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Cooper"
                },
                {
                    "first": "W. J.",
                    "initial": "W.J.",
                    "last": "Towner"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Conway"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Ruane"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Bourlie"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Asselah"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Berg"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Zeuzem"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Rosenberg"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Agarwal"
                },
                {
                    "first": "C. A.M.",
                    "initial": "C.A.M.",
                    "last": "Stedman"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Mo"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Dvory Sobol"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Han"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "McNally"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Osinusi"
                },
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Brainard"
                },
                {
                    "first": "J. G.",
                    "initial": "J.G.",
                    "last": "McHutchison"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Mazzotta"
                },
                {
                    "first": "T. T.",
                    "initial": "T.T.",
                    "last": "Tran"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Gordon"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Patel"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Reau"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Mangia"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Sulkowski"
                }
            ],
            "doi": "10.1056/NEJMoa1512612",
            "firstpage": "2608",
            "issn": "00284793",
            "lastpage": "2617",
            "pmid": "26575258",
            "pub_year": 2015,
            "title": "Sofosbuvir and velpatasvir for HCV Genotype 2 and 3 infection",
            "volume": "373"
        },
        "b0010": {
            "authors": [
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Feld"
                },
                {
                    "first": "I. M.",
                    "initial": "I.M.",
                    "last": "Jacobson"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Hode"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Asselah"
                },
                {
                    "first": "P. J.",
                    "initial": "P.J.",
                    "last": "Ruane"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Gruener"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Abergel"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Mangia"
                },
                {
                    "first": "C. L.",
                    "initial": "C.L.",
                    "last": "Lai"
                },
                {
                    "first": "H. L.Y.",
                    "initial": "H.L.Y.",
                    "last": "Chan"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Mazzotta"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Moreno"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Yoshida"
                },
                {
                    "first": "S. D.",
                    "initial": "S.D.",
                    "last": "Shafran"
                },
                {
                    "first": "W. J.",
                    "initial": "W.J.",
                    "last": "Towner"
                },
                {
                    "first": "T. T.",
                    "initial": "T.T.",
                    "last": "Tran"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "McNally"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Osinusi"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Svarovskaia"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Brainard"
                },
                {
                    "first": "J. G.",
                    "initial": "J.G.",
                    "last": "McHutchison"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Agarwal"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Zeuzem"
                }
            ],
            "doi": "10.1056/NEJMoa1512610",
            "firstpage": "2599",
            "issn": "00284793",
            "lastpage": "2607",
            "pmid": "26571066",
            "pub_year": 2015,
            "title": "Sofosbuvir and velpatasvir for hcv genotype 1, 2, 4, 5, and 6 infection",
            "volume": "373"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Calogero",
                    "initial": "C.",
                    "last": "Camm\u00e0"
                },
                {
                    "first": "Salvatore",
                    "initial": "S.",
                    "last": "Petta"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Cabibbo"
                },
                {
                    "first": "Matteo",
                    "initial": "M.",
                    "last": "Ruggeri"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Enea"
                },
                {
                    "first": "Raffaele",
                    "initial": "R.",
                    "last": "Bruno"
                },
                {
                    "first": "Vincenza",
                    "initial": "V.",
                    "last": "Capursi"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Gasbarrini"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Alberti"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Crax\u00ec"
                }
            ],
            "doi": "10.1016/j.jhep.2013.05.019",
            "firstpage": "658",
            "issn": "01688278",
            "lastpage": "666",
            "pmid": "23707373",
            "pub_year": 2013,
            "title": "Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C",
            "volume": "59"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Michael L.",
                    "initial": "M.L.",
                    "last": "Volk"
                }
            ],
            "doi": "10.1093/jac/dkq157",
            "firstpage": "1327",
            "issn": "03057453",
            "lastpage": "1329",
            "pmid": "20460398",
            "pub_year": 2010,
            "title": "Antiviral therapy for hepatitis C: Why are so few patients being treated?",
            "volume": "65"
        },
        "b0025": null,
        "b0030": {
            "authors": [
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Franco"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Tural"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Nevot"
                },
                {
                    "first": "Jos\u00e9",
                    "initial": "J.",
                    "last": "Molt\u00f3"
                },
                {
                    "first": "J\u00fcrgen Kurt",
                    "initial": "J.K.",
                    "last": "Rockstroh"
                },
                {
                    "first": "Bonaventura",
                    "initial": "B.",
                    "last": "Clotet"
                },
                {
                    "first": "Miguel Angel",
                    "initial": "M.A.",
                    "last": "Martinez"
                }
            ],
            "doi": "10.1053/j.gastro.2014.05.010",
            "firstpage": "599",
            "issn": "00165085",
            "lastpage": "e1",
            "pmid": "24859204",
            "pub_year": 2014,
            "title": "Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man",
            "volume": "147"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "Sulkowski"
                },
                {
                    "first": "David F.",
                    "initial": "D.F.",
                    "last": "Gardiner"
                },
                {
                    "first": "Maribel",
                    "initial": "M.",
                    "last": "Rodriguez-Torres"
                },
                {
                    "first": "K. Rajender",
                    "initial": "K.R.",
                    "last": "Reddy"
                },
                {
                    "first": "Tarek",
                    "initial": "T.",
                    "last": "Hassanein"
                },
                {
                    "first": "Ira",
                    "initial": "I.",
                    "last": "Jacobson"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Lawitz"
                },
                {
                    "first": "Anna S.",
                    "initial": "A.S.",
                    "last": "Lok"
                },
                {
                    "first": "Federico",
                    "initial": "F.",
                    "last": "Hinestrosa"
                },
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Thuluvath"
                },
                {
                    "first": "Howard",
                    "initial": "H.",
                    "last": "Schwartz"
                },
                {
                    "first": "David R.",
                    "initial": "D.R.",
                    "last": "Nelson"
                },
                {
                    "first": "Gregory T.",
                    "initial": "G.T.",
                    "last": "Everson"
                },
                {
                    "first": "Timothy",
                    "initial": "T.",
                    "last": "Eley"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "Wind-Rotolo"
                },
                {
                    "first": "Shu Pang",
                    "initial": "S.P.",
                    "last": "Huang"
                },
                {
                    "first": "Min",
                    "initial": "M.",
                    "last": "Gao"
                },
                {
                    "first": "Dennis",
                    "initial": "D.",
                    "last": "Hernandez"
                },
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "McPhee"
                },
                {
                    "first": "Diane",
                    "initial": "D.",
                    "last": "Sherman"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Hindes"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Symonds"
                },
                {
                    "first": "Claudio",
                    "initial": "C.",
                    "last": "Pasquinelli"
                },
                {
                    "first": "Dennis M.",
                    "initial": "D.M.",
                    "last": "Grasela"
                }
            ],
            "doi": "10.1056/NEJMoa1306218",
            "firstpage": "211",
            "issn": "00284793",
            "lastpage": "221",
            "pub_year": 2014,
            "title": "Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection",
            "volume": "370"
        },
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "Jane P.",
                    "initial": "J.P.",
                    "last": "Messina"
                },
                {
                    "first": "Isla",
                    "initial": "I.",
                    "last": "Humphreys"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Flaxman"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Brown"
                },
                {
                    "first": "Graham S.",
                    "initial": "G.S.",
                    "last": "Cooke"
                },
                {
                    "first": "Oliver G.",
                    "initial": "O.G.",
                    "last": "Pybus"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Barnes"
                }
            ],
            "doi": "10.1002/hep.27259",
            "firstpage": "77",
            "issn": "02709139",
            "lastpage": "87",
            "pmid": "25069599",
            "pub_year": 2015,
            "title": "Global distribution and prevalence of hepatitis C virus genotypes",
            "volume": "61"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Jonathan W.",
                    "initial": "J.W.",
                    "last": "Yewdell"
                }
            ],
            "doi": "10.1016/j.immuni.2006.09.005",
            "firstpage": "533",
            "issn": "10747613",
            "lastpage": "543",
            "pmid": "17046682",
            "pub_year": 2006,
            "title": "Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell Responses",
            "volume": "25"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Giugliano"
                },
                {
                    "first": "Filiz",
                    "initial": "F.",
                    "last": "Oezkan"
                },
                {
                    "first": "Mathias",
                    "initial": "M.",
                    "last": "Bedrejowski"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Kudla"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Reiser"
                },
                {
                    "first": "Sergei",
                    "initial": "S.",
                    "last": "Viazov"
                },
                {
                    "first": "Norbert",
                    "initial": "N.",
                    "last": "Scherbaum"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Roggendorf"
                },
                {
                    "first": "Joerg",
                    "initial": "J.",
                    "last": "Timm"
                }
            ],
            "doi": "10.1002/hep.23096",
            "firstpage": "707",
            "issn": "02709139",
            "lastpage": "716",
            "pmid": "19637188",
            "pub_year": 2009,
            "title": "Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3",
            "volume": "50"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Annette",
                    "initial": "A.",
                    "last": "Von Delft"
                },
                {
                    "first": "Isla S.",
                    "initial": "I.S.",
                    "last": "Humphreys"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Brown"
                },
                {
                    "first": "Katja",
                    "initial": "K.",
                    "last": "Pfafferott"
                },
                {
                    "first": "Michaela",
                    "initial": "M.",
                    "last": "Lucas"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Klenerman"
                },
                {
                    "first": "Georg M.",
                    "initial": "G.M.",
                    "last": "Lauer"
                },
                {
                    "first": "Andrea L.",
                    "initial": "A.L.",
                    "last": "Cox"
                },
                {
                    "first": "Silvana",
                    "initial": "S.",
                    "last": "Gaudieri"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Barnes"
                }
            ],
            "doi": "10.1136/gutjnl-2014-308724",
            "firstpage": "112",
            "issn": "00175749",
            "lastpage": "123",
            "pmid": "26092843",
            "pub_year": 2016,
            "title": "The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design",
            "volume": "65"
        },
        "b0065": null,
        "b0070": null,
        "b0075": {
            "authors": [
                {
                    "first": "Christabel",
                    "initial": "C.",
                    "last": "Kelly"
                },
                {
                    "first": "Leo",
                    "initial": "L.",
                    "last": "Swadling"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Brown"
                },
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Capone"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Folgori"
                },
                {
                    "first": "Mariolina",
                    "initial": "M.",
                    "last": "Salio"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Klenerman"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Barnes"
                }
            ],
            "doi": "10.1002/eji.201444686",
            "firstpage": "309",
            "issn": "00142980",
            "lastpage": "316",
            "pmid": "25263407",
            "pub_year": 2015,
            "title": "Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes",
            "volume": "45"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Farzin",
                    "initial": "F.",
                    "last": "Roohvand"
                },
                {
                    "first": "Niloufar",
                    "initial": "N.",
                    "last": "Kossari"
                }
            ],
            "doi": "10.1517/13543776.2012.673589",
            "firstpage": "391",
            "issn": "13543776",
            "lastpage": "415",
            "pmid": "22455502",
            "pub_year": 2012,
            "title": "Advances in hepatitis C virus vaccines, part two: Advances in hepatitis C virus vaccine formulations and modalities",
            "volume": "22"
        },
        "b0085": null,
        "b0090": {
            "authors": [
                {
                    "first": "Donald B.",
                    "initial": "D.B.",
                    "last": "Smith"
                },
                {
                    "first": "Jens",
                    "initial": "J.",
                    "last": "Bukh"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Kuiken"
                },
                {
                    "first": "A. Scott",
                    "initial": "A.S.",
                    "last": "Muerhoff"
                },
                {
                    "first": "Charles M.",
                    "initial": "C.M.",
                    "last": "Rice"
                },
                {
                    "first": "Jack T.",
                    "initial": "J.T.",
                    "last": "Stapleton"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Simmonds"
                }
            ],
            "doi": "10.1002/hep.26744",
            "firstpage": "318",
            "issn": "02709139",
            "lastpage": "327",
            "pmid": "24115039",
            "pub_year": 2014,
            "title": "Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource",
            "volume": "59"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Antrobus"
                },
                {
                    "first": "Lynda",
                    "initial": "L.",
                    "last": "Coughlan"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Dicks"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1038/mt.2013.284",
            "firstpage": "668",
            "issn": "15250016",
            "lastpage": "674",
            "pmid": "24374965",
            "pub_year": 2014,
            "title": "Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens",
            "volume": "22"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Magdalena",
                    "initial": "M.",
                    "last": "Plebanski"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Harris"
                },
                {
                    "first": "Catherine E.M.",
                    "initial": "C.E.M.",
                    "last": "Allsopp"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Thomas"
                },
                {
                    "first": "Guy T.",
                    "initial": "G.T.",
                    "last": "Layton"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1038/nbt1197-1280",
            "firstpage": "1280",
            "issn": "10870156",
            "lastpage": "1284",
            "pmid": "9359112",
            "pub_year": 1997,
            "title": "A protein particle vaccine containing multiple malaria epitopes",
            "volume": "15"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Hamill"
                },
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Lillie"
                },
                {
                    "first": "Lenias",
                    "initial": "L.",
                    "last": "Hwenda"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Milicic"
                },
                {
                    "first": "Hazel C.",
                    "initial": "H.C.",
                    "last": "Poyntz"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Helen A.",
                    "initial": "H.A.",
                    "last": "Fletcher"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1093/cid/ciq015",
            "firstpage": "1",
            "issn": "10584838",
            "lastpage": "7",
            "pmid": "21148512",
            "pub_year": 2011,
            "title": "Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza a vaccine, MVA-NP+M1",
            "volume": "52"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Andr\u00e9"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Seed"
                },
                {
                    "first": "Josef",
                    "initial": "J.",
                    "last": "Eberle"
                },
                {
                    "first": "Winfried",
                    "initial": "W.",
                    "last": "Schraut"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "B\u00fcltmann"
                },
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Haas"
                }
            ],
            "firstpage": "1497",
            "issn": "0022538X",
            "lastpage": "1503",
            "pmid": "9445053",
            "pub_year": 1998,
            "title": "Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage",
            "volume": "72"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "G\u00f6ran",
                    "initial": "G.",
                    "last": "Wadell"
                },
                {
                    "first": "Kalifa",
                    "initial": "K.",
                    "last": "Bojang"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                }
            ],
            "doi": "10.1371/journal.pone.0040385",
            "issn": "19326203",
            "pmid": "22808149",
            "pub_year": 2012,
            "title": "A novel chimpanzee adenovirus vector with low human seroprevalence: Improved systems for vector derivation and comparative immunogenicity",
            "volume": "7"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Hong Huang",
                    "initial": "H.H.",
                    "last": "Lin"
                },
                {
                    "first": "Surajit",
                    "initial": "S.",
                    "last": "Ray"
                },
                {
                    "first": "Songsak",
                    "initial": "S.",
                    "last": "Tongchusak"
                },
                {
                    "first": "Ellis L.",
                    "initial": "E.L.",
                    "last": "Reinherz"
                },
                {
                    "first": "Vladimir",
                    "initial": "V.",
                    "last": "Brusic"
                }
            ],
            "doi": "10.1186/1471-2172-9-8",
            "issn": "14712172",
            "pmid": "18366636",
            "pub_year": 2008,
            "title": "Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research",
            "volume": "9"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Hong Huang",
                    "initial": "H.H.",
                    "last": "Lin"
                },
                {
                    "first": "Guang Lan",
                    "initial": "G.L.",
                    "last": "Zhang"
                },
                {
                    "first": "Songsak",
                    "initial": "S.",
                    "last": "Tongchusak"
                },
                {
                    "first": "Ellis L.",
                    "initial": "E.L.",
                    "last": "Reinherz"
                },
                {
                    "first": "Vladimir",
                    "initial": "V.",
                    "last": "Brusic"
                }
            ],
            "doi": "10.1186/1471-2105-9-S1-S22",
            "issn": "14712105",
            "pmid": "19091022",
            "pub_year": 2008,
            "title": "Evaluation of MHC-II peptide binding prediction servers: Applications for vaccine research",
            "volume": "9"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Martin Closter",
                    "initial": "M.C.",
                    "last": "Jespersen"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                },
                {
                    "first": "Morten",
                    "initial": "M.",
                    "last": "Nielsen"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Marcatili"
                }
            ],
            "doi": "10.1093/nar/gkx346",
            "firstpage": "W24",
            "issn": "03051048",
            "lastpage": "W29",
            "pmid": "28472356",
            "pub_year": 2017,
            "title": "BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes",
            "volume": "45"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Leopold",
                    "initial": "L.",
                    "last": "Kong"
                },
                {
                    "first": "Kelli N.",
                    "initial": "K.N.",
                    "last": "Jackson"
                },
                {
                    "first": "Ian A.",
                    "initial": "I.A.",
                    "last": "Wilson"
                },
                {
                    "first": "Mansun",
                    "initial": "M.",
                    "last": "Law"
                }
            ],
            "doi": "10.1016/j.coviro.2015.04.001",
            "firstpage": "148",
            "issn": "18796257",
            "lastpage": "157",
            "pmid": "25932568",
            "pub_year": 2015,
            "title": "Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design",
            "volume": "11"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Arthur Y.",
                    "initial": "A.Y.",
                    "last": "Kim"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Kuntzen"
                },
                {
                    "first": "Joerg",
                    "initial": "J.",
                    "last": "Timm"
                },
                {
                    "first": "Brian E.",
                    "initial": "B.E.",
                    "last": "Nolan"
                },
                {
                    "first": "Melanie A.",
                    "initial": "M.A.",
                    "last": "Baca"
                },
                {
                    "first": "Laura L.",
                    "initial": "L.L.",
                    "last": "Reyor"
                },
                {
                    "first": "Andrew C.",
                    "initial": "A.C.",
                    "last": "Berical"
                },
                {
                    "first": "Andrea J.",
                    "initial": "A.J.",
                    "last": "Feller"
                },
                {
                    "first": "Kristin L.",
                    "initial": "K.L.",
                    "last": "Johnson"
                },
                {
                    "first": "Julian Schulze Zur",
                    "initial": "J.S.Z.",
                    "last": "Wiesch"
                },
                {
                    "first": "Gregory K.",
                    "initial": "G.K.",
                    "last": "Robbins"
                },
                {
                    "first": "Raymond T.",
                    "initial": "R.T.",
                    "last": "Chung"
                },
                {
                    "first": "Bruce D.",
                    "initial": "B.D.",
                    "last": "Walker"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Carrington"
                },
                {
                    "first": "Todd M.",
                    "initial": "T.M.",
                    "last": "Allen"
                },
                {
                    "first": "Georg M.",
                    "initial": "G.M.",
                    "last": "Lauer"
                }
            ],
            "doi": "10.1053/j.gastro.2010.09.042",
            "firstpage": "686",
            "issn": "00165085",
            "lastpage": "696.e1",
            "pub_year": 2011,
            "title": "Spontaneous control of HCV is associated with expression of HLA-B *57 and preservation of targeted epitopes",
            "volume": "140"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Fitzmaurice"
                },
                {
                    "first": "Danijela",
                    "initial": "D.",
                    "last": "Petrovic"
                },
                {
                    "first": "Narayan",
                    "initial": "N.",
                    "last": "Ramamurthy"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Simmons"
                },
                {
                    "first": "Shazma",
                    "initial": "S.",
                    "last": "Merani"
                },
                {
                    "first": "Silvana",
                    "initial": "S.",
                    "last": "Gaudieri"
                },
                {
                    "first": "Stuart",
                    "initial": "S.",
                    "last": "Sims"
                },
                {
                    "first": "Eugene",
                    "initial": "E.",
                    "last": "Dempsey"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Freitas"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Lea"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "McKiernan"
                },
                {
                    "first": "Suzanne",
                    "initial": "S.",
                    "last": "Norris"
                },
                {
                    "first": "Aideen",
                    "initial": "A.",
                    "last": "Long"
                },
                {
                    "first": "Dermot",
                    "initial": "D.",
                    "last": "Kelleher"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Klenerman"
                }
            ],
            "doi": "10.1136/gut.2010.228403",
            "firstpage": "1563",
            "issn": "00175749",
            "lastpage": "1571",
            "pmid": "21551190",
            "pub_year": 2011,
            "title": "Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection",
            "volume": "60"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Neumann-Haefelin"
                },
                {
                    "first": "J\u00f6rg",
                    "initial": "J.",
                    "last": "Timm"
                },
                {
                    "first": "Julia",
                    "initial": "J.",
                    "last": "Schmidt"
                },
                {
                    "first": "Nadine",
                    "initial": "N.",
                    "last": "Kersting"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Fitzmaurice"
                },
                {
                    "first": "Cesar",
                    "initial": "C.",
                    "last": "Oniangue-Ndza"
                },
                {
                    "first": "Michael N.",
                    "initial": "M.N.",
                    "last": "Kemper"
                },
                {
                    "first": "Isla",
                    "initial": "I.",
                    "last": "Humphreys"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "McKiernan"
                },
                {
                    "first": "Dermot",
                    "initial": "D.",
                    "last": "Kelleher"
                },
                {
                    "first": "Volker",
                    "initial": "V.",
                    "last": "Lohmann"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Bowness"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Huzly"
                },
                {
                    "first": "Hugo R.",
                    "initial": "H.R.",
                    "last": "Rosen"
                },
                {
                    "first": "Arthur Y.",
                    "initial": "A.Y.",
                    "last": "Kim"
                },
                {
                    "first": "Georg M.",
                    "initial": "G.M.",
                    "last": "Lauer"
                },
                {
                    "first": "Todd M.",
                    "initial": "T.M.",
                    "last": "Allen"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Barnes"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Roggendorf"
                },
                {
                    "first": "Hubert E.",
                    "initial": "H.E.",
                    "last": "Blum"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Thimme"
                }
            ],
            "doi": "10.1002/hep.23275",
            "firstpage": "54",
            "issn": "02709139",
            "lastpage": "62",
            "pmid": "20034048",
            "pub_year": 2010,
            "title": "Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope",
            "volume": "51"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Hans Georg",
                    "initial": "H.G.",
                    "last": "Rammensee"
                },
                {
                    "first": "Jutta",
                    "initial": "J.",
                    "last": "Bachmann"
                },
                {
                    "first": "Niels Philipp Nikolaus",
                    "initial": "N.P.N.",
                    "last": "Emmerich"
                },
                {
                    "first": "Oskar Alexander",
                    "initial": "O.A.",
                    "last": "Bachor"
                },
                {
                    "first": "Stefan",
                    "initial": "S.",
                    "last": "Stevanovi\u0107"
                }
            ],
            "doi": "10.1007/s002510050595",
            "firstpage": "213",
            "issn": "00937711",
            "lastpage": "219",
            "pmid": "10602881",
            "pub_year": 1999,
            "title": "SYFPEITHI: Database for MHC ligands and peptide motifs",
            "volume": "50"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Morten",
                    "initial": "M.",
                    "last": "Nielsen"
                },
                {
                    "first": "Claus",
                    "initial": "C.",
                    "last": "Lundegaard"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Blicher"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Sette"
                },
                {
                    "first": "Sune",
                    "initial": "S.",
                    "last": "Justesen"
                },
                {
                    "first": "S\u00f8ren",
                    "initial": "S.",
                    "last": "Buus"
                },
                {
                    "first": "Ole",
                    "initial": "O.",
                    "last": "Lund"
                }
            ],
            "doi": "10.1371/journal.pcbi.1000107",
            "issn": "1553734X",
            "pmid": "18604266",
            "pub_year": 2008,
            "title": "Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan",
            "volume": "4"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Marilyn",
                    "initial": "M.",
                    "last": "Kozak"
                }
            ],
            "doi": "10.1093/nar/15.20.8125",
            "firstpage": "8125",
            "issn": "03051048",
            "lastpage": "8148",
            "pmid": "3313277",
            "pub_year": 1987,
            "title": "An analysis of 5'-noncoding sequences from 699 vertebrate messenger rNAS",
            "volume": "15"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Sven",
                    "initial": "S.",
                    "last": "L\u00e9tourneau"
                },
                {
                    "first": "Eung Jun",
                    "initial": "E.J.",
                    "last": "Im"
                },
                {
                    "first": "Tumelo",
                    "initial": "T.",
                    "last": "Mashishi"
                },
                {
                    "first": "Choechoe",
                    "initial": "C.",
                    "last": "Brereton"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Bridgeman"
                },
                {
                    "first": "Hongbing",
                    "initial": "H.",
                    "last": "Yang"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Dorrell"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Dong"
                },
                {
                    "first": "Bette",
                    "initial": "B.",
                    "last": "Korber"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": "Tom\u00e1\u0161",
                    "initial": "T.",
                    "last": "Hanke"
                }
            ],
            "doi": "10.1371/journal.pone.0000984",
            "issn": "19326203",
            "pmid": "17912361",
            "pub_year": 2007,
            "title": "Design and pre-clinical evaluation of a universal HIV-1 vaccine",
            "volume": "2"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Donald B.",
                    "initial": "D.B.",
                    "last": "Smith"
                },
                {
                    "first": "Jens",
                    "initial": "J.",
                    "last": "Bukh"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Kuiken"
                },
                {
                    "first": "A. Scott",
                    "initial": "A.S.",
                    "last": "Muerhoff"
                },
                {
                    "first": "Charles M.",
                    "initial": "C.M.",
                    "last": "Rice"
                },
                {
                    "first": "Jack T.",
                    "initial": "J.T.",
                    "last": "Stapleton"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Simmonds"
                }
            ],
            "doi": "10.1002/hep.26744",
            "firstpage": "318",
            "issn": "02709139",
            "lastpage": "327",
            "pmid": "24115039",
            "pub_year": 2014,
            "title": "Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource",
            "volume": "59"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Andrew L.",
                    "initial": "A.L.",
                    "last": "Ferguson"
                },
                {
                    "first": "Jaclyn K.",
                    "initial": "J.K.",
                    "last": "Mann"
                },
                {
                    "first": "Saleha",
                    "initial": "S.",
                    "last": "Omarjee"
                },
                {
                    "first": "Thumbi",
                    "initial": "T.",
                    "last": "Ndung'u"
                },
                {
                    "first": "Bruce D.",
                    "initial": "B.D.",
                    "last": "Walker"
                },
                {
                    "first": "Arup K.",
                    "initial": "A.K.",
                    "last": "Chakraborty"
                }
            ],
            "doi": "10.1016/j.immuni.2012.11.022",
            "firstpage": "606",
            "issn": "10747613",
            "lastpage": "617",
            "pmid": "23521886",
            "pub_year": 2013,
            "title": "Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design",
            "volume": "38"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Jonathan M.",
                    "initial": "J.M.",
                    "last": "Carlson"
                },
                {
                    "first": "Anh Q.",
                    "initial": "A.Q.",
                    "last": "Le"
                },
                {
                    "first": "Aniqa",
                    "initial": "A.",
                    "last": "Shahid"
                },
                {
                    "first": "Zabrina L.",
                    "initial": "Z.L.",
                    "last": "Brumme"
                }
            ],
            "doi": "10.1016/j.tim.2014.12.008",
            "firstpage": "212",
            "issn": "0966842X",
            "lastpage": "224",
            "pmid": "25613992",
            "pub_year": 2015,
            "title": "HIV-1 adaptation to HLA: A window into virus-host immune interactions",
            "volume": "23"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Yohan",
                    "initial": "Y.",
                    "last": "Kim"
                },
                {
                    "first": "Kerrie",
                    "initial": "K.",
                    "last": "Vaughan"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Greenbaum"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                },
                {
                    "first": "Mansun",
                    "initial": "M.",
                    "last": "Law"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Sette"
                }
            ],
            "doi": "10.1371/journal.pone.0038028",
            "issn": "19326203",
            "pmid": "22675428",
            "pub_year": 2012,
            "title": "A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV)",
            "volume": "7"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Fuller"
                },
                {
                    "first": "Naglaa H.",
                    "initial": "N.H.",
                    "last": "Shoukry"
                },
                {
                    "first": "Toshifumi",
                    "initial": "T.",
                    "last": "Gushima"
                },
                {
                    "first": "David G.",
                    "initial": "D.G.",
                    "last": "Bowen"
                },
                {
                    "first": "Benoit",
                    "initial": "B.",
                    "last": "Callendret"
                },
                {
                    "first": "Katherine J.",
                    "initial": "K.J.",
                    "last": "Campbell"
                },
                {
                    "first": "Dana L.",
                    "initial": "D.L.",
                    "last": "Hasselschwert"
                },
                {
                    "first": "Austin L.",
                    "initial": "A.L.",
                    "last": "Hughes"
                },
                {
                    "first": "Christopher M.",
                    "initial": "C.M.",
                    "last": "Walker"
                }
            ],
            "doi": "10.1002/hep.23319",
            "firstpage": "378",
            "issn": "02709139",
            "lastpage": "387",
            "pub_year": 2010,
            "title": "Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection",
            "volume": "51"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Cheryl L.",
                    "initial": "C.L.",
                    "last": "Day"
                },
                {
                    "first": "Georg M.",
                    "initial": "G.M.",
                    "last": "Lauer"
                },
                {
                    "first": "Gregory K.",
                    "initial": "G.K.",
                    "last": "Robbins"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "McGovern"
                },
                {
                    "first": "Alysse G.",
                    "initial": "A.G.",
                    "last": "Wurcel"
                },
                {
                    "first": "Rajesh T.",
                    "initial": "R.T.",
                    "last": "Gandhi"
                },
                {
                    "first": "Raymond T.",
                    "initial": "R.T.",
                    "last": "Chung"
                },
                {
                    "first": "Bruce D.",
                    "initial": "B.D.",
                    "last": "Walker"
                }
            ],
            "doi": "10.1128/JVI.76.24.12584-12595.2002",
            "firstpage": "12584",
            "issn": "0022538X",
            "lastpage": "12595",
            "pmid": "12438584",
            "pub_year": 2002,
            "title": "Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection",
            "volume": "76"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Arash",
                    "initial": "A.",
                    "last": "Grakoui"
                },
                {
                    "first": "Naglaa H.",
                    "initial": "N.H.",
                    "last": "Shoukry"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Woollard"
                },
                {
                    "first": "Jin Hwan",
                    "initial": "J.H.",
                    "last": "Han"
                },
                {
                    "first": "Holly L.",
                    "initial": "H.L.",
                    "last": "Hanson"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Ghrayeb"
                },
                {
                    "first": "Krishna K.",
                    "initial": "K.K.",
                    "last": "Murthy"
                },
                {
                    "first": "Charles M.",
                    "initial": "C.M.",
                    "last": "Rice"
                },
                {
                    "first": "Christopher M.",
                    "initial": "C.M.",
                    "last": "Walker"
                }
            ],
            "doi": "10.1126/science.1088774",
            "firstpage": "659",
            "issn": "00368075",
            "lastpage": "662",
            "pmid": "14576438",
            "pub_year": 2003,
            "title": "HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help",
            "volume": "302"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Eung Jun",
                    "initial": "E.J.",
                    "last": "Im"
                },
                {
                    "first": "Jessie P.",
                    "initial": "J.P.",
                    "last": "Hong"
                },
                {
                    "first": "Yaowaluck",
                    "initial": "Y.",
                    "last": "Roshorm"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Bridgeman"
                },
                {
                    "first": "Sven",
                    "initial": "S.",
                    "last": "L\u00e9tourneau"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Liljestr\u00f6m"
                },
                {
                    "first": "Mary Jane",
                    "initial": "M.J.",
                    "last": "Potash"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Volsky"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": "Tom\u00e1\u0161",
                    "initial": "T.",
                    "last": "Hanke"
                }
            ],
            "doi": "10.1371/journal.ppat.1002041",
            "issn": "15537366",
            "pmid": "21625575",
            "pub_year": 2011,
            "title": "Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges",
            "volume": "7"
        },
        "b0225": {
            "authors": [
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Borthwick"
                },
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Ahmed"
                },
                {
                    "first": "Beatrice",
                    "initial": "B.",
                    "last": "Ondondo"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Hayes"
                },
                {
                    "first": "Annie",
                    "initial": "A.",
                    "last": "Rose"
                },
                {
                    "first": "Umar",
                    "initial": "U.",
                    "last": "Ebrahimsa"
                },
                {
                    "first": "Emma Jo",
                    "initial": "E.J.",
                    "last": "Hayton"
                },
                {
                    "first": "Antony",
                    "initial": "A.",
                    "last": "Black"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Bridgeman"
                },
                {
                    "first": "Maximillian",
                    "initial": "M.",
                    "last": "Rosario"
                },
                {
                    "first": "Adrian Vs",
                    "initial": "A.V.",
                    "last": "Hill"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Frahm"
                },
                {
                    "first": "Josephine",
                    "initial": "J.",
                    "last": "Cox"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Jill",
                    "initial": "J.",
                    "last": "Gilmour"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Dorrell"
                },
                {
                    "first": "Tom\u00e1\u0161",
                    "initial": "T.",
                    "last": "Hanke"
                }
            ],
            "doi": "10.1038/mt.2013.248",
            "firstpage": "464",
            "issn": "15250016",
            "lastpage": "475",
            "pmid": "24166483",
            "pub_year": 2014,
            "title": "Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1",
            "volume": "22"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Asif M.",
                    "initial": "A.M.",
                    "last": "Khan"
                },
                {
                    "first": "Olivo",
                    "initial": "O.",
                    "last": "Miotto"
                },
                {
                    "first": "A. T.",
                    "initial": "A.T.",
                    "last": "Heiny"
                },
                {
                    "first": "Jerome",
                    "initial": "J.",
                    "last": "Salmon"
                },
                {
                    "first": "K. N.",
                    "initial": "K.N.",
                    "last": "Srinivasan"
                },
                {
                    "first": "Eduardo J.M.",
                    "initial": "E.J.M.",
                    "last": "Nascimento"
                },
                {
                    "first": "Ernesto T.A.",
                    "initial": "E.T.A.",
                    "last": "Marques"
                },
                {
                    "first": "Vladimir",
                    "initial": "V.",
                    "last": "Brusic"
                },
                {
                    "first": "Tin Wee",
                    "initial": "T.W.",
                    "last": "Tan"
                },
                {
                    "first": "J. Thomas",
                    "initial": "J.T.",
                    "last": "August"
                }
            ],
            "doi": "10.1016/j.cellimm.2007.02.005",
            "firstpage": "141",
            "issn": "00088749",
            "lastpage": "147",
            "pmid": "17434154",
            "pub_year": 2006,
            "title": "A systematic bioinformatics approach for selection of epitope-based vaccine targets",
            "volume": "244"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Beatrice",
                    "initial": "B.",
                    "last": "Ondondo"
                },
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Brennan"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Crome"
                },
                {
                    "first": "Tom\u00e1\u0161",
                    "initial": "T.",
                    "last": "Hanke"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.06.068",
            "firstpage": "5594",
            "issn": "0264410X",
            "lastpage": "5601",
            "pmid": "23831324",
            "pub_year": 2013,
            "title": "Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice",
            "volume": "31"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Gerrit",
                    "initial": "G.",
                    "last": "Koopman"
                },
                {
                    "first": "Niels",
                    "initial": "N.",
                    "last": "Beenhakker"
                },
                {
                    "first": "Ivonne",
                    "initial": "I.",
                    "last": "Nieuwenhuis"
                },
                {
                    "first": "Gaby",
                    "initial": "G.",
                    "last": "Doxiadis"
                },
                {
                    "first": "Petra",
                    "initial": "P.",
                    "last": "Mooij"
                },
                {
                    "first": "Jan W.",
                    "initial": "J.W.",
                    "last": "Drijfhout"
                },
                {
                    "first": "Josef",
                    "initial": "J.",
                    "last": "Koestler"
                },
                {
                    "first": "Tomas",
                    "initial": "T.",
                    "last": "Hanke"
                },
                {
                    "first": "Zahra",
                    "initial": "Z.",
                    "last": "Fagrouch"
                },
                {
                    "first": "Ernst J.",
                    "initial": "E.J.",
                    "last": "Verschoor"
                },
                {
                    "first": "Ronald E.",
                    "initial": "R.E.",
                    "last": "Bontrop"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Wagner"
                },
                {
                    "first": "Willy M.J.M.",
                    "initial": "W.M.J.M.",
                    "last": "Bogers"
                },
                {
                    "first": "Cornelis J.M.",
                    "initial": "C.J.M.",
                    "last": "Melief"
                }
            ],
            "doi": "10.1097/QAD.0000000000000047",
            "firstpage": "2841",
            "issn": "02699370",
            "lastpage": "2851",
            "pmid": "24105029",
            "pub_year": 2013,
            "title": "DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge",
            "volume": "27"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Christa",
                    "initial": "C.",
                    "last": "Firbas"
                },
                {
                    "first": "Bernd",
                    "initial": "B.",
                    "last": "Jilma"
                },
                {
                    "first": "Erich",
                    "initial": "E.",
                    "last": "Tauber"
                },
                {
                    "first": "Vera",
                    "initial": "V.",
                    "last": "Buerger"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Jelovcan"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Lingnau"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Buschle"
                },
                {
                    "first": "J\u00fcrgen",
                    "initial": "J.",
                    "last": "Frisch"
                },
                {
                    "first": "Christoph S.",
                    "initial": "C.S.",
                    "last": "Klade"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.03.009",
            "firstpage": "4343",
            "issn": "0264410X",
            "lastpage": "4353",
            "pmid": "16581161",
            "pub_year": 2006,
            "title": "Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects",
            "volume": "24"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Arash",
                    "initial": "A.",
                    "last": "MemarnejadA."
                },
                {
                    "first": "Farzin",
                    "initial": "F.",
                    "last": "Roohvand"
                },
                {
                    "first": "Arash",
                    "initial": "A.",
                    "last": "Arashkia"
                },
                {
                    "first": "Sima",
                    "initial": "S.",
                    "last": "Rafati"
                },
                {
                    "first": "Mohammad Ali",
                    "initial": "M.A.",
                    "last": "Shokrgozar"
                }
            ],
            "doi": "10.2174/092986609788681788",
            "firstpage": "842",
            "issn": "09298665",
            "lastpage": "850",
            "pmid": "19601916",
            "pub_year": 2009,
            "title": "Polytope DNA vaccine development against hepatitis C virus: A streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice",
            "volume": "16"
        },
        "b0255": {
            "authors": [
                {
                    "first": "Arash",
                    "initial": "A.",
                    "last": "Arashkia"
                },
                {
                    "first": "Farzin",
                    "initial": "F.",
                    "last": "Roohvand"
                },
                {
                    "first": "Arash",
                    "initial": "A.",
                    "last": "Memarnejadian"
                },
                {
                    "first": "Mohammad Reza",
                    "initial": "M.R.",
                    "last": "Aghasadeghi"
                },
                {
                    "first": "Sima",
                    "initial": "S.",
                    "last": "Rafati"
                }
            ],
            "doi": "10.1007/s11262-009-0417-3",
            "firstpage": "44",
            "issn": "09208569",
            "lastpage": "52",
            "pmid": "19882243",
            "pub_year": 2010,
            "title": "Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice",
            "volume": "40"
        },
        "b0260": {
            "authors": [
                {
                    "first": "Kelly P.",
                    "initial": "K.P.",
                    "last": "Burke"
                },
                {
                    "first": "Supriya",
                    "initial": "S.",
                    "last": "Munshaw"
                },
                {
                    "first": "William O.",
                    "initial": "W.O.",
                    "last": "Osburn"
                },
                {
                    "first": "Jordana",
                    "initial": "J.",
                    "last": "Levine"
                },
                {
                    "first": "Lin",
                    "initial": "L.",
                    "last": "Liu"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Sidney"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Sette"
                },
                {
                    "first": "Stuart C.",
                    "initial": "S.C.",
                    "last": "Ray"
                },
                {
                    "first": "Andrea L.",
                    "initial": "A.L.",
                    "last": "Cox"
                }
            ],
            "doi": "10.4049/jimmunol.1103008",
            "firstpage": "5177",
            "issn": "00221767",
            "lastpage": "5188",
            "pmid": "22508927",
            "pub_year": 2012,
            "title": "Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection",
            "volume": "188"
        },
        "b0265": {
            "authors": [
                {
                    "first": "Will",
                    "initial": "W.",
                    "last": "Fischer"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Perkins"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Theiler"
                },
                {
                    "first": "Tanmoy",
                    "initial": "T.",
                    "last": "Bhattacharya"
                },
                {
                    "first": "Karina",
                    "initial": "K.",
                    "last": "Yusim"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Funkhouser"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Kuiken"
                },
                {
                    "first": "Barton",
                    "initial": "B.",
                    "last": "Haynes"
                },
                {
                    "first": "Norman L.",
                    "initial": "N.L.",
                    "last": "Letvin"
                },
                {
                    "first": "Bruce D.",
                    "initial": "B.D.",
                    "last": "Walker"
                },
                {
                    "first": "Beatrice H.",
                    "initial": "B.H.",
                    "last": "Hahn"
                },
                {
                    "first": "Bette T.",
                    "initial": "B.T.",
                    "last": "Korber"
                }
            ],
            "doi": "10.1038/nm1461",
            "firstpage": "100",
            "issn": "10788956",
            "lastpage": "106",
            "pmid": "17187074",
            "pub_year": 2007,
            "title": "Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants",
            "volume": "13"
        },
        "b0270": {
            "authors": [
                {
                    "first": "Bette T.",
                    "initial": "B.T.",
                    "last": "Korber"
                },
                {
                    "first": "Norman L.",
                    "initial": "N.L.",
                    "last": "Letvin"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                }
            ],
            "doi": "10.1128/JVI.00114-09",
            "firstpage": "8300",
            "issn": "0022538X",
            "lastpage": "8314",
            "pmid": "19439471",
            "pub_year": 2009,
            "title": "T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces",
            "volume": "83"
        },
        "b0275": {
            "authors": [
                {
                    "first": "Dan H.",
                    "initial": "D.H.",
                    "last": "Barouch"
                },
                {
                    "first": "Kara L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Nathaniel L.",
                    "initial": "N.L.",
                    "last": "Simmons"
                },
                {
                    "first": "Sharon L.",
                    "initial": "S.L.",
                    "last": "King"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Abbink"
                },
                {
                    "first": "Lori F.",
                    "initial": "L.F.",
                    "last": "Maxfield"
                },
                {
                    "first": "Ying Hua",
                    "initial": "Y.H.",
                    "last": "Sun"
                },
                {
                    "first": "Annalena",
                    "initial": "A.",
                    "last": "La Porte"
                },
                {
                    "first": "Ambryice M.",
                    "initial": "A.M.",
                    "last": "Riggs"
                },
                {
                    "first": "Diana M.",
                    "initial": "D.M.",
                    "last": "Lynch"
                },
                {
                    "first": "Sarah L.",
                    "initial": "S.L.",
                    "last": "Clark"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Backus"
                },
                {
                    "first": "James R.",
                    "initial": "J.R.",
                    "last": "Perry"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Seaman"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Carville"
                },
                {
                    "first": "Keith G.",
                    "initial": "K.G.",
                    "last": "Mansfield"
                },
                {
                    "first": "James J.",
                    "initial": "J.J.",
                    "last": "Szinger"
                },
                {
                    "first": "Will",
                    "initial": "W.",
                    "last": "Fischer"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Muldoon"
                },
                {
                    "first": "Bette",
                    "initial": "B.",
                    "last": "Korber"
                }
            ],
            "doi": "10.1038/nm.2089",
            "firstpage": "319",
            "issn": "10788956",
            "lastpage": "323",
            "pmid": "20173752",
            "pub_year": 2010,
            "title": "Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys",
            "volume": "16"
        },
        "b0280": {
            "authors": [
                {
                    "first": "Sultan",
                    "initial": "S.",
                    "last": "Abdul-Jawad"
                },
                {
                    "first": "Beatrice",
                    "initial": "B.",
                    "last": "Ondondo"
                },
                {
                    "first": "Andy",
                    "initial": "A.",
                    "last": "Van Hateren"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Gardner"
                },
                {
                    "first": "Tim",
                    "initial": "T.",
                    "last": "Elliott"
                },
                {
                    "first": "Bette",
                    "initial": "B.",
                    "last": "Korber"
                },
                {
                    "first": "Tom\u00e1\u0161",
                    "initial": "T.",
                    "last": "Hanke"
                }
            ],
            "doi": "10.1038/mt.2015.210",
            "firstpage": "375",
            "issn": "15250016",
            "lastpage": "384",
            "pmid": "26581160",
            "pub_year": 2016,
            "title": "Increased valency of conserved-mosaic vaccines enhances the breadth and depth of Epitope recognition",
            "volume": "24"
        },
        "b0285": {
            "authors": [
                {
                    "first": "Karina",
                    "initial": "K.",
                    "last": "Yusim"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Dilan"
                },
                {
                    "first": "Erica",
                    "initial": "E.",
                    "last": "Borducchi"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Stanley"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Giorgi"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Fischer"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Theiler"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Marcotrigiano"
                },
                {
                    "first": "Bette",
                    "initial": "B.",
                    "last": "Korber"
                },
                {
                    "first": "Dan H.",
                    "initial": "D.H.",
                    "last": "Barouch"
                }
            ],
            "doi": "10.1128/CVI.00605-12",
            "firstpage": "302",
            "issn": "15566811",
            "lastpage": "305",
            "pmid": "23221002",
            "pub_year": 2013,
            "title": "Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains",
            "volume": "20"
        }
    },
    "body_text": [
        {
            "endOffset": 19463,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 19349,
                    "startOffset": 19345
                },
                "b0060": {
                    "endOffset": 19462,
                    "startOffset": 19458
                }
            },
            "secId": "s0005",
            "sentence": "However, T-cell specificity is distinct between HCV genotypes [11] with limited T-cell cross-reactivity against common sequence variants at frequently detected T-cell targets [12].",
            "startOffset": 19283,
            "title": "Introduction"
        },
        {
            "endOffset": 23324,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "A circulating HCV isolate from a subtype within the dataset, with a highest homology to the overall consensus was selected and included in conserved immunogens.",
            "startOffset": 23164,
            "title": "Selection of a circulating isolate for final immunogen design"
        },
        {
            "endOffset": 37367,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 37366,
                    "startOffset": 37359
                },
                "b0195": {
                    "endOffset": 37366,
                    "startOffset": 37359
                }
            },
            "secId": "s0090",
            "sentence": "One issue with an approach that uses conserved segments in immunogen design is the possibility that there is a lack of immunological pressure driving viral mutations associated with genetic conservation in these regions [36,37].",
            "startOffset": 37139,
            "title": "Discussion"
        },
        {
            "endOffset": 40910,
            "parents": [],
            "secId": "s0090",
            "sentence": "We show that HCV conserved immunogens encoded in a simian adenoviral vector (ChAdOx1) induce strong HCV-specific T-cell responses that produce IFN-\u03b3 and TNF-\u03b1 in mice and are cross-reactive with multiple HCV subtype antigens.",
            "startOffset": 40685,
            "title": "Discussion"
        },
        {
            "endOffset": 18475,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 18474,
                    "startOffset": 18471
                }
            },
            "secId": "s0005",
            "sentence": "Notably, a recent World Health Organization (WHO) report shows that even with effective treatment, available new HCV infections in 2015 exceeded the number of people dying of the disease or receiving curative therapy, leading to an increase in HCV prevalence [8].",
            "startOffset": 18212,
            "title": "Introduction"
        },
        {
            "endOffset": 26466,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Mice were sacrificed 2 weeks post-immunization.",
            "startOffset": 26419,
            "title": "Animals"
        },
        {
            "endOffset": 30029,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Next, we determined sequence homology between genotypes at defined conserved segments.",
            "startOffset": 29943,
            "title": "Conserved sequence segments are highly homologous between genotypes"
        },
        {
            "endOffset": 39125,
            "parents": [],
            "secId": "s0090",
            "sentence": "Notably, immune-dominant but highly variable CD8 epitopes such as NS31073CINGVCWTV and NS31406KLVALGINAV are not included in our HCV conserved immunogens.",
            "startOffset": 38971,
            "title": "Discussion"
        },
        {
            "endOffset": 19128,
            "parents": [],
            "secId": "s0005",
            "sentence": "In addition, HCV exists as a viral population of closely related genetic variants (quasispecies) within the infected host.",
            "startOffset": 19006,
            "title": "Introduction"
        },
        {
            "endOffset": 33002,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "T-cell epitopes for HCV genotypes 2, 4, 5 and 6 have rarely been evaluated experimentally using genotype specific peptides and were therefore not included in our analysis.",
            "startOffset": 32831,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 24466,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "A blast analysis was performed (https://blast.ncbi.nlm.nih.gov) to ensure there was no homology with the human genome at junctional regions.",
            "startOffset": 24326,
            "title": "Prediction analysis for T- and B-cell epitopes and proteasomal cleavage sites"
        },
        {
            "endOffset": 38970,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 38850,
                    "startOffset": 38846
                },
                "b0210": {
                    "endOffset": 38969,
                    "startOffset": 38962
                },
                "b0215": {
                    "endOffset": 38969,
                    "startOffset": 38962
                }
            },
            "secId": "s0090",
            "sentence": "This is in line with the observation that viral escape at CD4 T-cell epitopes is relatively unusual [39], which may contribute to the central role that CD4 cells play in spontaneous resolution of acute HCV infection [40,41].",
            "startOffset": 38746,
            "title": "Discussion"
        },
        {
            "endOffset": 42583,
            "parents": [],
            "secId": "s0090",
            "sentence": "We show through in silico analysis that conserved regions are highly populated with epitopes predicted by online epitope prediction servers and by those described in natural infection.",
            "startOffset": 42399,
            "title": "Discussion"
        },
        {
            "endOffset": 21081,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 20749,
                    "startOffset": 20746
                },
                "b0085": {
                    "endOffset": 20971,
                    "startOffset": 20967
                },
                "b0090": {
                    "endOffset": 21080,
                    "startOffset": 21076
                }
            },
            "secId": "s0005",
            "sentence": "We used world-wide HCV prevalence data [9] to inform the rational design of three distinct HCV immunogens targeting (i) genotype-1 alone - the most prevalent genotype globally (GT1), (ii) genotypes-1 and 3 - the two most commonly infecting genotypes in the UK [17] and world wide (GT1/3); and (iii) genotypes-1 to 6 - covering all common HCV genotypes globally (GT1-6) [18].",
            "startOffset": 20707,
            "title": "Introduction"
        },
        {
            "endOffset": 26010,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Experiments were performed at the Biomedical Services Building, Oxford according to UK Home Office Regulations (licence numbers 30/2744 and 30/3293) and approved by the local ethical review board at the University of Oxford.",
            "startOffset": 25786,
            "title": "Animals"
        },
        {
            "endOffset": 27405,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Spot-forming units (SFU) were counted on an automated ELISpot plate reader.",
            "startOffset": 27330,
            "title": "Ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays"
        },
        {
            "endOffset": 36857,
            "parents": [],
            "secId": "s0090",
            "sentence": "We showed that conserved segments contained protein sequence that was more than 91.4% homologous between genotypes and are expected therefore to prime HCV specific T-cell responses that are highly cross-reactive between genotypes.",
            "startOffset": 36627,
            "title": "Discussion"
        },
        {
            "endOffset": 21815,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Full-length genotype HCV sequences from the HCV sequence database www.hcv.lanl.gov, and in-house genotype 3 sequences were used for immunogen design (n = 216, Supplementary Table S1).",
            "startOffset": 21632,
            "title": "The selection of HCV sequences"
        },
        {
            "endOffset": 31249,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 31248,
                    "startOffset": 31241
                },
                "b0125": {
                    "endOffset": 31248,
                    "startOffset": 31241
                }
            },
            "secId": "s0075",
            "sentence": "The potential immunogenicity of conserved immunogens was evaluated using an online epitope prediction algorithm (http://www.cbs.dtu.dk/NetMHC) shown to predict MHC class-I epitopes with high accuracy [24,25].",
            "startOffset": 31041,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 17788,
            "parents": [],
            "secId": "s0005",
            "sentence": "Hepatitis C virus (HCV) infects approximately 170 million people worldwide and is a leading cause of end-stage liver disease.",
            "startOffset": 17663,
            "title": "Introduction"
        },
        {
            "endOffset": 26160,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "All animal experiments complied with the ARRIVE guidelines and were carried out in accordance with the U.K. Animals (Scientific Procedure) Act, 1986.",
            "startOffset": 26011,
            "title": "Animals"
        },
        {
            "endOffset": 22257,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 22256,
                    "startOffset": 22252
                }
            },
            "secId": "s0015",
            "sentence": "Genotype-7 was not included as only one sequence has been published [18].",
            "startOffset": 22184,
            "title": "The selection of HCV sequences"
        },
        {
            "endOffset": 35468,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "High magnitude T-cell responses against HCV peptides from subtypes 1a (mean 935 SFU/106), 1b (mean 1474 SFU/106) and 3a (mean 1112 SFU/106) were demonstrated (Fig. 4b).",
            "startOffset": 35300,
            "title": "Conserved segment vaccines are highly immunogenic in mice"
        },
        {
            "endOffset": 24802,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0060": {
                    "endOffset": 24801,
                    "startOffset": 24797
                }
            },
            "secId": "s0035",
            "sentence": "HCV genotype-1 and genotype-3 epitopes were obtained from the immune epitope database resource (IEDB) and from those experimentally defined in our laboratory [12].",
            "startOffset": 24639,
            "title": "Analysis of HCV T-cell epitopes in natural infection"
        },
        {
            "endOffset": 37602,
            "parents": [],
            "secId": "s0090",
            "sentence": "We therefore assessed whether T- and B-cell epitopes could be found in these regions through in silico analysis using online prediction programs and through an evaluation of HCV specific T-cell epitopes described in natural infection.",
            "startOffset": 37368,
            "title": "Discussion"
        },
        {
            "endOffset": 32007,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 31952,
                    "startOffset": 31948
                }
            },
            "secId": "s0075",
            "sentence": "Of note, two E2 antigenic sites now considered prime targets for B-cell vaccine design (AS412 and AS434) [27] are not included in the designed conserved immunogens.",
            "startOffset": 31843,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 27690,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Mann-Whitney tests (for non-Gaussian distributions) were used to determine statistical differences of the means between each HCV genotype stimulus and the DMSO control.",
            "startOffset": 27522,
            "title": "Ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays"
        },
        {
            "endOffset": 23685,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Epitope prediction analysis was run using online epitope prediction programs NetMHC, Syfpeithi and BIMAS with a cut-off for strong epitope binders of <0.5, >20, and >100, respectively.",
            "startOffset": 23501,
            "title": "Prediction analysis for T- and B-cell epitopes and proteasomal cleavage sites"
        },
        {
            "endOffset": 32569,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "HCV genotype-1 CD4 T-cell epitopes mapped to conserved rather than variable viral segments (p < .0001), whereas CD8 epitopes were equally distributed across the viral genome (Supplementary Fig. S4).",
            "startOffset": 32371,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 29470,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Significant overlap of conserved segments was observed at 1141 AA positions; with 1043 (91.4%) homologous AAs between conserved consensus sequences defined for GT1, GT1/3 and GT1-6 (Supplementary Fig. S2).",
            "startOffset": 29265,
            "title": "Definition of HCV conserved segments with significant overlap between genotypes"
        },
        {
            "endOffset": 32370,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "T-cell epitopes defined in natural infection: Next, we determined whether CD4 and CD8 restricted epitopes described in natural infection were detected in conserved viral segments; 89 of 215 CD8 (41.4%) and 170 of 320 CD4 (53%) of HCV genotype-1 epitopes described in natural infection mapped to conserved viral segments within the HCV genotype 1 dataset (Fig. 3).",
            "startOffset": 32007,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 35804,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 35803,
                    "startOffset": 35796
                },
                "b0060": {
                    "endOffset": 35803,
                    "startOffset": 35796
                }
            },
            "secId": "s0085",
            "sentence": "When assessed using intracellular cytokine assay and flow cytometric analysis vaccine-induced CD4 and CD8 T-cells produce IFN\u03b3 and TNF\u03b1 on stimulation with HCV genotype 1 and 3 peptides (Fig. 4c and d), indicating that designed conserved HCV immunogens are immunogenic and capable of generating cross-reactive immune responses [11,12].",
            "startOffset": 35469,
            "title": "Conserved segment vaccines are highly immunogenic in mice"
        },
        {
            "endOffset": 17955,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17954,
                    "startOffset": 17949
                },
                "b0010": {
                    "endOffset": 17954,
                    "startOffset": 17949
                }
            },
            "secId": "s0005",
            "sentence": "HCV treatment has become highly effective in the era of directly acting antivirals (DAA), with the latest drugs showing high efficacy against all HCV genotypes [1,2].",
            "startOffset": 17789,
            "title": "Introduction"
        },
        {
            "endOffset": 30162,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Over 80% sequence homology was observed at all defined conserved segments between subtype and overall consensus sequences (Fig. 2a).",
            "startOffset": 30030,
            "title": "Conserved sequence segments are highly homologous between genotypes"
        },
        {
            "endOffset": 40225,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 40110,
                    "startOffset": 40106
                }
            },
            "secId": "s0090",
            "sentence": "Although the E2 antigenic sites (AS412 and AS434) that are now considered prime targets for B-cell vaccine design were not included in HCV conserved immunogens [27], it may be prudent to combine vaccine platform technologies with the aim of inducing both B- and T-cell responses.",
            "startOffset": 39946,
            "title": "Discussion"
        },
        {
            "endOffset": 20285,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 20284,
                    "startOffset": 20280
                }
            },
            "secId": "s0005",
            "sentence": "In this study, we introduce an immunogen design approach based on the selection of HCV genomic regions that are highly conserved between HCV genotypes with the exclusion of variable HCV epitopes [16].",
            "startOffset": 20085,
            "title": "Introduction"
        },
        {
            "endOffset": 26418,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Three groups of four age and sex matched C57BL6 mice were vaccinated intramuscularly (dose of 1 \u00d7 108 infectious units (I.U.) in 40 l per mouse) at 4\u20136 weeks of age with ChAdOx1 vaccine containing the long version of gt1-6 immunogen (ChAdOx1-gt1-6L-TPA-LS).",
            "startOffset": 26161,
            "title": "Animals"
        },
        {
            "endOffset": 20399,
            "parents": [],
            "secId": "s0005",
            "sentence": "We hypothesise that conserved HCV sequences carry a detrimental fitness cost if mutations occur in these regions.",
            "startOffset": 20286,
            "title": "Introduction"
        },
        {
            "endOffset": 31410,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Between 176 and 215 strong binding MHC class-I epitopes were predicted for the short immunogens, and 251\u2013318 for the longer immunogens (Supplementary Fig. S3a).",
            "startOffset": 31250,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 39528,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 39527,
                    "startOffset": 39523
                }
            },
            "secId": "s0090",
            "sentence": "However, we predict that excluding these may potentially lead to the \u201cup-ranking\u201d of sub-dominant epitopes, as shown for a conserved HIV vaccine, where serially deleting immunodominant epitopes tripled the frequencies of immune responses to previously subdominant epitopes [42].",
            "startOffset": 39250,
            "title": "Discussion"
        },
        {
            "endOffset": 28590,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Cell permeabilization was performed the next day using BD Perm/Wash\u2122 Buffer (Fix/Perm kit, BD Biosciences, San Jose, CA, USA) followed by intracellular staining using IFN\u03b3-PE (phycoerythrin) and TNF\u03b1-FITC (1:50).",
            "startOffset": 28378,
            "title": "Intracellular staining assays"
        },
        {
            "endOffset": 29056,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "HCV sequence diversity was calculated for GT1, GT1/3 and GT1-6 sequence datasets, and conserved viral segments with 95.5% (GT1), 94.7% (GT1/3) and 90.2% (GT1-6) homology were obtained using a cut-off at 25% of total variability within each dataset (Fig. 1a).",
            "startOffset": 28798,
            "title": "Definition of HCV conserved segments with significant overlap between genotypes"
        },
        {
            "endOffset": 42398,
            "parents": [],
            "secId": "s0090",
            "sentence": "In summary, we have developed HCV simian adenoviral vectored vaccines specifically designed to target all HCV genotypes by encoding HCV conserved genomic segments from all major HCV genotypes.",
            "startOffset": 42206,
            "title": "Discussion"
        },
        {
            "endOffset": 37139,
            "parents": [],
            "secId": "s0090",
            "sentence": "Ultimately, we used naturally circulating HCV isolates rather than consensus sequences in the immunogen design since consensus sequences may contain both artificial epitopes (not found in the wild) and dominant escape mutations at epitopes where the restricting HLA type is common.",
            "startOffset": 36858,
            "title": "Discussion"
        },
        {
            "endOffset": 19005,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 19004,
                    "startOffset": 19001
                }
            },
            "secId": "s0005",
            "sentence": "Whilst HCV genotype-1 is the most common genotype world wide, other genotypes are distributed in areas with high HCV prevalence with genotype-2 common in Asia, genotype-3 in the UK, Asia and former USSR, genotype-4, 5 and 7 in Africa, and genotype-6 in Asia [9].",
            "startOffset": 18743,
            "title": "Introduction"
        },
        {
            "endOffset": 41303,
            "parents": [],
            "refoffsets": {
                "b0245": {
                    "endOffset": 41302,
                    "startOffset": 41298
                }
            },
            "secId": "s0090",
            "sentence": "Alternative vaccine developmental strategies include those encoding single HCV isolates or epitopes [47].",
            "startOffset": 41198,
            "title": "Discussion"
        },
        {
            "endOffset": 42000,
            "parents": [],
            "refoffsets": {
                "b0250": {
                    "endOffset": 41658,
                    "startOffset": 41651
                },
                "b0255": {
                    "endOffset": 41658,
                    "startOffset": 41651
                },
                "b0260": {
                    "endOffset": 41763,
                    "startOffset": 41759
                },
                "b0265": {
                    "endOffset": 41999,
                    "startOffset": 41992
                },
                "b0270": {
                    "endOffset": 41999,
                    "startOffset": 41992
                }
            },
            "secId": "s0090",
            "sentence": "Other approaches that specifically aim to induce broad, cross-reactive HCV-specific T-cell responses include the selection of single conserved T-cell epitopes [48,49], ancestral sequences designed to minimise differences between the immunogen and circulating viruses [50] or recombinant mosaic vaccines that encode computationally generated immunogens through machine learning; these are designed to closely resemble natural proteins to ensure optimal antigen processing and maximize T-cell coverage [51,52].",
            "startOffset": 41492,
            "title": "Discussion"
        },
        {
            "endOffset": 22183,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 22182,
                    "startOffset": 22178
                }
            },
            "secId": "s0015",
            "sentence": "HCV subtypes were chosen according to common circulating viral strains [18].",
            "startOffset": 22107,
            "title": "The selection of HCV sequences"
        },
        {
            "endOffset": 38298,
            "parents": [],
            "secId": "s0090",
            "sentence": "We also show that epitopes described in natural infection are contained within conserved regions indicating that these have the potential to prime HCV specific response in humans in vivo.",
            "startOffset": 38111,
            "title": "Discussion"
        },
        {
            "endOffset": 38486,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 38485,
                    "startOffset": 38481
                }
            },
            "secId": "s0090",
            "sentence": "This result is in keeping with a published analysis of HCV epitopes deposited on the IEDB showing that frequently recognized T-cells epitopes correlate with low sequence variability [38].",
            "startOffset": 38299,
            "title": "Discussion"
        },
        {
            "endOffset": 38111,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 38110,
                    "startOffset": 38106
                }
            },
            "secId": "s0090",
            "sentence": "Whilst we recognise that in silico algorithmic epitope prediction only remodels a part of the complex epitope presentation pathway (peptide binding to MHC complexes), this is the most selective step of the epitope presentation pathway and contributes to about 90% of immunodominance [10].",
            "startOffset": 37823,
            "title": "Discussion"
        },
        {
            "endOffset": 22873,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "To define conserved segments in the dataset, we selected a threshold equal to the lowest quartile (denoted \u0398) of the overall diversity distribution.",
            "startOffset": 22725,
            "title": "Definition of conserved HCV viral segments"
        },
        {
            "endOffset": 41097,
            "parents": [],
            "secId": "s0090",
            "sentence": "A limitation of this study is that epitope presentation and T-cell specificity in mice is based on H-2Dd molecules and therefore distinct from human HLA-based human epitope presentation.",
            "startOffset": 40911,
            "title": "Discussion"
        },
        {
            "endOffset": 33878,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "As conserved HCV immunogens are concatenated from multiple sequence segments, T-cell responses may be generated to artificial non-HCV regions between adjacent conserved segments.",
            "startOffset": 33700,
            "title": "T-cell epitopes in junction regions and abrogation through linker design"
        },
        {
            "endOffset": 34133,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Approximately 15% of all predicted strong binding T-cell epitopes were located in junction areas between conserved segments.",
            "startOffset": 34009,
            "title": "T-cell epitopes in junction regions and abrogation through linker design"
        },
        {
            "endOffset": 20707,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore vaccine induced T-cells responses to conserved viral segments that are cross-reactive against multiple HCV genotypes will be capable of controlling and eliminating the virus during primary infection as viral mutation to escape T-cell recognition will carry a significant fitness cost to the virus.",
            "startOffset": 20400,
            "title": "Introduction"
        },
        {
            "endOffset": 31842,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 31700,
                    "startOffset": 31696
                }
            },
            "secId": "s0075",
            "sentence": "Using BepiPred-2.0 (http://www.cbs.dtu.dk/services/BepiPred-2.0/) [26] between 17 and 19 strong binding B-cell epitopes were predicted for short immunogens, and 18\u201323 for long immunogens (Supplementary Table S4).",
            "startOffset": 31630,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 29264,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Conserved segments were defined within each dataset and these were concatenated to form \u201clong\u201d immunogens (Fig. 1b): 30 for GT1 (total 1543 AA), 27 for GT1/3 (total 1443 AA) and 24 for GT1-6 (total 1350 AA).",
            "startOffset": 29057,
            "title": "Definition of HCV conserved segments with significant overlap between genotypes"
        },
        {
            "endOffset": 26839,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "In brief, pre-coated ELISpot plates (with anti-IFN\u03b3 monoclonal antibody (0.5 \u03bcg/well, Mabtech) were blocked with R10 (RPMI Sigma, 10% FCS, Penicillin and Streptomycin added).",
            "startOffset": 26665,
            "title": "Ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays"
        },
        {
            "endOffset": 36209,
            "parents": [],
            "secId": "s0090",
            "sentence": "We have addressed this through the design and generation of a T-cell vaccine using a simian adenoviral vector encoding immunogens from HCV regions that are conserved between viral genotypes.",
            "startOffset": 36019,
            "title": "Discussion"
        },
        {
            "endOffset": 36359,
            "parents": [],
            "secId": "s0090",
            "sentence": "The vaccines generated are predicated to contain multiple HCV human epitopes that are cross-reactive between major genotypes in a pre-clinical model.",
            "startOffset": 36210,
            "title": "Discussion"
        },
        {
            "endOffset": 19884,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 19796,
                    "startOffset": 19792
                },
                "b0075": {
                    "endOffset": 19883,
                    "startOffset": 19879
                }
            },
            "secId": "s0005",
            "sentence": "However, we observed reduced T-cell cross-reactivity of vaccine-induced T-cells against other genotypes [13] and against circulating viral variants at epitopes derived from the same genotype [15].",
            "startOffset": 19688,
            "title": "Introduction"
        },
        {
            "endOffset": 25541,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 25540,
                    "startOffset": 25536
                }
            },
            "secId": "s0040",
            "sentence": "ChAdOx1 HCV vaccines were manufactured by the Viral Vector Core Facility (Jenner Institute, University of Oxford, Oxford, UK) [23].",
            "startOffset": 25410,
            "title": "Vaccine production"
        },
        {
            "endOffset": 18079,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 17996,
                    "startOffset": 17993
                },
                "b0020": {
                    "endOffset": 18078,
                    "startOffset": 18073
                },
                "b0025": {
                    "endOffset": 18078,
                    "startOffset": 18073
                }
            },
            "secId": "s0005",
            "sentence": "However, the new drugs are expensive [3] and treatment rates remain low ranging from 3.5% in Europe to 21% in the US [4,5].",
            "startOffset": 17956,
            "title": "Introduction"
        },
        {
            "endOffset": 29873,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "As vaccines encoding immunogens over 1000 AA may be difficult to manufacture, we designed additional shorter immunogens by ranking conserved sequence segments by length and selecting the longest segments up to a total of \u223c 1000 AA, with resulting immunogen lengths of 1043, 1010 and 1041 AA for HCV GT1, GT1/3 and GT1-6, respectively (subsequently termed \u201cshort immunogens\u201d/\u2018S\u2019, e.g. Gt1-6S) (Fig. 1c).",
            "startOffset": 29471,
            "title": "Definition of HCV conserved segments with significant overlap between genotypes"
        },
        {
            "endOffset": 25776,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Immunogen expression was evaluated in HEK 293a cells by Western blot using anti-HCV core 1b antibody (C7-50, AB2740, Abcam); this detects AA sequence 21\u201340 (DVKFPGVGQIVGGVYLLPR) of HCV core and is contained within all HCV immunogens\u201d.",
            "startOffset": 25542,
            "title": "Vaccine production"
        },
        {
            "endOffset": 42206,
            "parents": [],
            "refoffsets": {
                "b0275": {
                    "endOffset": 42069,
                    "startOffset": 42062
                },
                "b0280": {
                    "endOffset": 42069,
                    "startOffset": 42062
                },
                "b0285": {
                    "endOffset": 42106,
                    "startOffset": 42102
                }
            },
            "secId": "s0090",
            "sentence": "This approach has shown some promise in animal models of HIV [53,54] and pre-clinical studies of HCV [55] although T-cells induced by mosaic vaccines may still preferentially target variable viral regions.",
            "startOffset": 42001,
            "title": "Discussion"
        },
        {
            "endOffset": 22586,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A sliding window (W) of 20 amino-acid (AA) starting at position zero and advancing one AA at a time was used to measure Hamming distance between all pairs of sequences in the alignment.",
            "startOffset": 22401,
            "title": "Definition of conserved HCV viral segments"
        },
        {
            "endOffset": 39945,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 39849,
                    "startOffset": 39842
                },
                "b0225": {
                    "endOffset": 39944,
                    "startOffset": 39940
                },
                "b0230": {
                    "endOffset": 39747,
                    "startOffset": 39743
                },
                "b0235": {
                    "endOffset": 39849,
                    "startOffset": 39842
                },
                "b0240": {
                    "endOffset": 39863,
                    "startOffset": 39859
                }
            },
            "secId": "s0090",
            "sentence": "Furthermore, strong T-cell responses to conserved regions subdominant in natural infection were readily detected when evaluating conserved vaccines for other highly variable viruses such as HIV [34,43], and dengue [44], and high magnitudes of HIV-specific T-cells inhibiting HIV replication were detected in mice [34,45] macaques [46], and in a Phase I clinical trial using a conserved segment vaccine approach [43].",
            "startOffset": 39529,
            "title": "Discussion"
        },
        {
            "endOffset": 23163,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "A consensus sequence was generated for each dataset (GT1, GT1/3 and GT1-6); hereafter named \u201coverall consensus\u201d, and all subtypes (e.g. for genotype-1 and genotype-3 in the GT1/3 analysis); hereafter named \u201csubtype consensus\u201d.",
            "startOffset": 22937,
            "title": "Selection of a circulating isolate for final immunogen design"
        },
        {
            "endOffset": 37822,
            "parents": [],
            "secId": "s0090",
            "sentence": "In silico epitope prediction confirmed the presence of multiple proteasomal cleavage sites and high numbers of strong T- and B-cell binders in conserved regions suggesting that these are able to induce immune responses.",
            "startOffset": 37603,
            "title": "Discussion"
        },
        {
            "endOffset": 18211,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 18210,
                    "startOffset": 18205
                },
                "b0035": {
                    "endOffset": 18210,
                    "startOffset": 18205
                }
            },
            "secId": "s0005",
            "sentence": "Furthermore, successful treatment does not prevent re-infection, a particular problem in intra-venous drug using populations [6,7].",
            "startOffset": 18080,
            "title": "Introduction"
        },
        {
            "endOffset": 24325,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 24324,
                    "startOffset": 24317
                },
                "b0105": {
                    "endOffset": 24324,
                    "startOffset": 24317
                }
            },
            "secId": "s0030",
            "sentence": "Predicted strong binders were abrogated using linkers consisting of 2\u20136 AA (glycine/proline or glycine/serine combinations) as previously described [20,21].",
            "startOffset": 24169,
            "title": "Prediction analysis for T- and B-cell epitopes and proteasomal cleavage sites"
        },
        {
            "endOffset": 33144,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 33143,
                    "startOffset": 33136
                },
                "b0145": {
                    "endOffset": 33143,
                    "startOffset": 33136
                },
                "b0150": {
                    "endOffset": 33143,
                    "startOffset": 33136
                }
            },
            "secId": "s0075",
            "sentence": "We also assessed whether epitopes linked to spontaneous resolution in natural HCV infection were included in the conserved immunogens [28\u201330].",
            "startOffset": 33002,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 42727,
            "parents": [],
            "secId": "s0090",
            "sentence": "These vaccines generate high magnitude HCV-specific T-cell responses that cross-react with multiple HCV subtypes in a pre-clinical mouse model.",
            "startOffset": 42584,
            "title": "Discussion"
        },
        {
            "endOffset": 27032,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "200,000 PBMCs/well were stimulated for 18 h with HCV peptide sets (3 \u03bcg/ml), DMSO and concanavalin A (10 \u03bcg, Sigma) serving as negative and positive controls, in duplicates for each condition.",
            "startOffset": 26840,
            "title": "Ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays"
        },
        {
            "endOffset": 28266,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "BD GolgiPlug\u2122 was added (4 \u03bcl/mL) 1 h later, cells incubated overnight (37 C), stained with fixable-NIR live/dead dye (Life Technologies, Carlsbad, CA, USA) at 1:1000 dilution, and CD3-eflour 450, CD8-peridinin chlorophyll protein (perCp) Cy5.5, and CD4-AlexFlour700 (all 1:50) antibodies.",
            "startOffset": 27977,
            "title": "Intracellular staining assays"
        },
        {
            "endOffset": 36018,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 36017,
                    "startOffset": 36013
                }
            },
            "secId": "s0090",
            "sentence": "One of the key obstacles in generating an effective vaccine for HCV is the extensive variability of the HCV genome and the geographical distribution of genetically distinct viral genotypes globally [35].",
            "startOffset": 35815,
            "title": "Discussion"
        },
        {
            "endOffset": 40556,
            "parents": [],
            "secId": "s0090",
            "sentence": "Although in silico analysis and the assessment of T-cell epitopes in natural infection predict that the conserved segment HCV vaccines will generate HCV specific immunity, concatenating conserved fragments into a chimeric protein may impact on protein processing and presentation, and therefore on vaccine-induced T-cell responses.",
            "startOffset": 40225,
            "title": "Discussion"
        },
        {
            "endOffset": 26664,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0060": {
                    "endOffset": 26663,
                    "startOffset": 26656
                },
                "b0065": {
                    "endOffset": 26663,
                    "startOffset": 26656
                }
            },
            "secId": "s0050",
            "sentence": "Splenocytes were isolated from harvested spleens and evaluated in ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays as previously described [12,13].",
            "startOffset": 26517,
            "title": "Ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays"
        },
        {
            "endOffset": 19282,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 19281,
                    "startOffset": 19277
                }
            },
            "secId": "s0005",
            "sentence": "Immunodominant T-cell responses in natural HCV infection are known to focus on a small number of epitopes that often show high sequence variability [10].",
            "startOffset": 19129,
            "title": "Introduction"
        },
        {
            "endOffset": 18742,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 18741,
                    "startOffset": 18738
                }
            },
            "secId": "s0005",
            "sentence": "A major challenge for HCV vaccine development is the extensive viral variability of HCV that exists as seven major genotypes globally that are approximately 80% genetically homologous, and numerous HCV subtypes [9].",
            "startOffset": 18527,
            "title": "Introduction"
        },
        {
            "endOffset": 35053,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 35052,
                    "startOffset": 35048
                },
                "b0165": {
                    "endOffset": 34871,
                    "startOffset": 34867
                },
                "b0190": {
                    "endOffset": 34996,
                    "startOffset": 34992
                }
            },
            "secId": "s0085",
            "sentence": "Final constructs included linkers to abrogate artificial epitopes, a Kozak sequence to maximize protein expression [33] and the tissue plasminogen activator leader sequence (TPA-LS) to optimize peptide presentation (Supplementary Table S2) [36], and were encoded in the simian adenovirus ChAdOx1 [19].",
            "startOffset": 34752,
            "title": "Conserved segment vaccines are highly immunogenic in mice"
        },
        {
            "endOffset": 28377,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Cells were fixed in 1% formaldehyde for 20 min at 4 \u00b0C, and re-suspended in PBS for overnight storage at 4 \u00b0C.",
            "startOffset": 28267,
            "title": "Intracellular staining assays"
        },
        {
            "endOffset": 24638,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "T-cell epitopes/targets were mapped along the HCV genome to assess the association of these with genomic variability.",
            "startOffset": 24521,
            "title": "Analysis of HCV T-cell epitopes in natural infection"
        },
        {
            "endOffset": 33625,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 33624,
                    "startOffset": 33620
                }
            },
            "secId": "s0075",
            "sentence": "A protective epitope at position NS5B2841 has been described in genotype-1 infection and is contained in the HCV GT1/3a and HCV GT1-6 constructs, but as a variant (NS5B2841VRMVLMTHF) that is non-immunogenic (Table 1) [30].",
            "startOffset": 33403,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 36626,
            "parents": [],
            "secId": "s0090",
            "sentence": "Sequence datasets generated for immunogen design used full-length HCV sequences only; this approach ensured equal coverage of conserved and variable viral regions, since variable viral regions are more difficult to sequence and underrepresented in sequence databases.",
            "startOffset": 36359,
            "title": "Discussion"
        },
        {
            "endOffset": 27329,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "All ELISpot assays were strongly positive for concanavalin A. HCV genotype-1a (H77), genotype-1b (J4b) and genotype-3 (K3a) peptides of 15\u201318 AA in length overlapping by 11 AA spanning the whole HCV genome and grouped into pools representing HCV viral proteins (e.g. core, E1, E2, NS2) were used.",
            "startOffset": 27033,
            "title": "Ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays"
        },
        {
            "endOffset": 19687,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 19686,
                    "startOffset": 19679
                },
                "b0070": {
                    "endOffset": 19686,
                    "startOffset": 19679
                }
            },
            "secId": "s0005",
            "sentence": "We have previously shown that HCV vaccine strategies using simian adenovectors encoding HCV genotype-1b non-structural regions induce high magnitudes of HCV specific T-cells at epitopes dominant in natural infection [13,14].",
            "startOffset": 19463,
            "title": "Introduction"
        },
        {
            "endOffset": 22106,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Sequences from different research groups and countries were selected for each strain and manually checked for human origin.",
            "startOffset": 21983,
            "title": "The selection of HCV sequences"
        },
        {
            "endOffset": 39249,
            "parents": [],
            "secId": "s0090",
            "sentence": "Some T-cell epitopes previously linked to the spontaneous resolution of HCV infection were also excluded from our immunogen.",
            "startOffset": 39125,
            "title": "Discussion"
        },
        {
            "endOffset": 28708,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "All flow cytometry was performed on a BD LSRII machine and analysed using FlowJo vX.0.7 (Treestar, Ashland, OR, USA).",
            "startOffset": 28591,
            "title": "Intracellular staining assays"
        },
        {
            "endOffset": 18527,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, a HCV vaccine remains an important goal.",
            "startOffset": 18476,
            "title": "Introduction"
        },
        {
            "endOffset": 22400,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Sequence diversity (normalized raw diversity, NDR) was calculated using pairwise Hamming distance.",
            "startOffset": 22302,
            "title": "Definition of conserved HCV viral segments"
        },
        {
            "endOffset": 41198,
            "parents": [],
            "secId": "s0090",
            "sentence": "To properly address this vaccines will need to be assessed humanized pre-clinical models and humans.",
            "startOffset": 41098,
            "title": "Discussion"
        },
        {
            "endOffset": 30430,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Overall, high mean similarities were observed between subtype consensuses and overall consensuses; 97.2% (GT1a) and 95.8% (GT1b) for the GT1 analyses, 91.9% (GT1) and 94.1% (GT3) for the GT1/3 analyses, and 90.2% (GT2) to 94.6% (GT1) for the GT1-6 analyses (Fig. 2b).",
            "startOffset": 30163,
            "title": "Conserved sequence segments are highly homologous between genotypes"
        },
        {
            "endOffset": 35211,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 35210,
                    "startOffset": 35206
                }
            },
            "secId": "s0085",
            "sentence": "Immunogen expression was demonstrated by Western blot using the monoclonal antibody against HCV core in infected human embryonic kidney cells (Fig. 4a) [34].",
            "startOffset": 35054,
            "title": "Conserved segment vaccines are highly immunogenic in mice"
        },
        {
            "endOffset": 35299,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "HCV GT1-6-TPA showed high levels of expression and was further assessed in C57BL6 mice.",
            "startOffset": 35212,
            "title": "Conserved segment vaccines are highly immunogenic in mice"
        },
        {
            "endOffset": 34692,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Junction regions were then reassessed, showing a reduction of strong predicted class-I binders in junction areas by 39% (GT1), 41% (GT1/3) and 24% (GT1-6) for the long conserved immunogens, respectively (Supplementary Fig. S5).",
            "startOffset": 34465,
            "title": "T-cell epitopes in junction regions and abrogation through linker design"
        },
        {
            "endOffset": 24168,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Junctions between two concatenated conserved segments were assessed for strong binders using two independent prediction algorithms for HLA class-I and class-II types at HLA population frequency over 2% (NCBI database).",
            "startOffset": 23950,
            "title": "Prediction analysis for T- and B-cell epitopes and proteasomal cleavage sites"
        },
        {
            "endOffset": 34464,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "As identical linkers may lead to dimerization during protein expression a variety of linkers was used.",
            "startOffset": 34362,
            "title": "T-cell epitopes in junction regions and abrogation through linker design"
        },
        {
            "endOffset": 21591,
            "parents": [],
            "secId": "s0005",
            "sentence": "We assessed designed antigens for immunogenicity using HLA epitope prediction programs, through the analysis of epitopes described in natural HCV infection and finally through evaluating vaccine immunogenicity in vivo in pre-clinical mouse studies.",
            "startOffset": 21343,
            "title": "Introduction"
        },
        {
            "endOffset": 21343,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 21164,
                    "startOffset": 21160
                }
            },
            "secId": "s0005",
            "sentence": "Novel conserved immunogens were encoded in a simian adenoviral vector ChAdOx1 [19], known to be capable of inducing high magnitude T-cell responses, which also circumvents the issue of pre-existing immunity to adenoviral vectors that may limit vaccine efficacy.",
            "startOffset": 21082,
            "title": "Introduction"
        },
        {
            "endOffset": 27521,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Positive responses were determined by calculating (mean SFU/106PBMC in test wells - negative control wells)+ 3\u00d7 SD.",
            "startOffset": 27406,
            "title": "Ex vivo interferon-(IFN)-\u03b3-linked ELISpot assays"
        },
        {
            "endOffset": 23500,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Prediction of proteasomal cleavage sites was run using server NetChop 3.1, (version C-term 3.0).",
            "startOffset": 23404,
            "title": "Prediction analysis for T- and B-cell epitopes and proteasomal cleavage sites"
        },
        {
            "endOffset": 31040,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Using computer algorithms: Using an online prediction algorithm (http://www.cbs.dtu.dk/NetChop), between 357 and 374 proteasomal cleavage sites were predicted for short conserved immunogens, with 462 and 545 cleavage sites predicted for long immunogens (Supplementary Table S3).",
            "startOffset": 30762,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 34008,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 34007,
                    "startOffset": 34000
                },
                "b0160": {
                    "endOffset": 34007,
                    "startOffset": 34000
                }
            },
            "secId": "s0080",
            "sentence": "The immunogenicity of junction regions was evaluated using online epitope prediction servers (NetCTL, BIMAS, Sythpeithi) [31,32].",
            "startOffset": 33879,
            "title": "T-cell epitopes in junction regions and abrogation through linker design"
        },
        {
            "endOffset": 25141,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 25140,
                    "startOffset": 25133
                },
                "b0110": {
                    "endOffset": 25100,
                    "startOffset": 25096
                },
                "b0115": {
                    "endOffset": 25140,
                    "startOffset": 25133
                }
            },
            "secId": "s0040",
            "sentence": "Conserved HCV immunogens were synthetically produced using \u201chumanized\u201d amino acid codons (GeneArt, ThermoFisher Scientific) [22] and cloned into a pENTR4 vector [19,23].",
            "startOffset": 24972,
            "title": "Vaccine production"
        },
        {
            "endOffset": 23805,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Potential immunogenicity of HCV immunogens was evaluated using the NetMHC prediction server (v3.4) for T-cell epitopes.",
            "startOffset": 23686,
            "title": "Prediction analysis for T- and B-cell epitopes and proteasomal cleavage sites"
        },
        {
            "endOffset": 31629,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The number of predicted strong binders was associated with immunogen length, and conserved segments were well populated with predicted CD8 epitopes of a wide range of different HLA types (Supplementary Fig. S3b and c).",
            "startOffset": 31411,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 42852,
            "parents": [],
            "secId": "s0090",
            "sentence": "This study paves the way for the assessment of an HCV T-cell vaccine in with the potential to target multiple HCV genotypes.",
            "startOffset": 42728,
            "title": "Discussion"
        },
        {
            "endOffset": 30669,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Natural HCV isolates optimally matched to the overall consensus were used in the final immunogens (Supplementary Table S2), as using consensus sequences differing from natural HCV isolates may lead to T-cells that target non-HCV epitopes.",
            "startOffset": 30431,
            "title": "Conserved sequence segments are highly homologous between genotypes"
        },
        {
            "endOffset": 38745,
            "parents": [],
            "secId": "s0090",
            "sentence": "In addition, we show here that if HCV genotype-1-specific CD4 and CD8 T-cell targets are analysed separately, CD4 epitopes preferentially map to conserved regions, whereas CD8 epitopes are equally distributed throughout conserved and variable viral segments.",
            "startOffset": 38487,
            "title": "Discussion"
        },
        {
            "endOffset": 27976,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Mouse splenocytes at 1 \u00d7 106 cells/100 \u03bcL were stimulated with HCV genotype-1a and -3a peptide pools covering all HCV proteins at 2 \u03bcg/ml or PMA (phorbol 12-myristate 13-acetate)/ionomycin (50 and 500 ng/mL respectively), or unstimulated (DMSO; 3 ng/mL).",
            "startOffset": 27722,
            "title": "Intracellular staining assays"
        },
        {
            "endOffset": 23949,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "B-cell epitopes were predicted with BepiPred 2.0 using a cut-off for strong binding epitopes 0.55 and an epitope prediction length of 5\u201320 AAs.",
            "startOffset": 23806,
            "title": "Prediction analysis for T- and B-cell epitopes and proteasomal cleavage sites"
        },
        {
            "endOffset": 22724,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A window size of 20 AA was selected to contain potential CD4 and CD8 epitopes (8\u201312 AA and 11\u201316 AA respectively (Supplementary Fig. S1).",
            "startOffset": 22587,
            "title": "Definition of conserved HCV viral segments"
        },
        {
            "endOffset": 41491,
            "parents": [],
            "secId": "s0090",
            "sentence": "A clear disadvantage with these approaches is that these may have limited applicability in a global strategy where human populations are HLA diverse, and multiple HCV genotypes circulate.",
            "startOffset": 41304,
            "title": "Discussion"
        },
        {
            "endOffset": 25409,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Coding cassettes within the pENTR4 vector were cloned into ChAdOx1 plasmids (Thermo Fisher Scientific LR gateway cloning procedure) and then linearized with PmeI and transfected into T-REx\u2122-293 cells (Thermo Fisher Scientific) for generation of viral vector vaccines.",
            "startOffset": 25142,
            "title": "Vaccine production"
        },
        {
            "endOffset": 24951,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Epitopes were crosschecked with primary publications and duplications, epitope variants and epitopes described in non-human organisms were excluded.",
            "startOffset": 24803,
            "title": "Analysis of HCV T-cell epitopes in natural infection"
        },
        {
            "endOffset": 34361,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 34325,
                    "startOffset": 34321
                },
                "b0105": {
                    "endOffset": 34302,
                    "startOffset": 34298
                }
            },
            "secId": "s0080",
            "sentence": "To avoid priming of T-cell responses against artificial epitopes, those predicted by two prediction servers were abrogated through the insertion of glycine/proline [21] or glycine/serine [20] AA linkers (Supplementary Fig. S5).",
            "startOffset": 34134,
            "title": "T-cell epitopes in junction regions and abrogation through linker design"
        },
        {
            "endOffset": 32830,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Similar results albeit at lower numbers were observed when analysing HCV genotype-3 specific epitopes, with 17 of 48 CD8 (35.4%) and 9 of 14 CD4 (64.3%) HCV genotype-3 specific epitopes mapping to conserved viral segments within the HCV GT1/3 dataset (Fig. 3).",
            "startOffset": 32570,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 20085,
            "parents": [],
            "secId": "s0005",
            "sentence": "An effective global T-cell vaccine will need to generate T-cell responses capable of recognising viral variant epitopes between both quasispecies, and between people infected with different genotypes.",
            "startOffset": 19885,
            "title": "Introduction"
        },
        {
            "endOffset": 21982,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Three different sequence datasets were generated: (a) HCV genotype-1 (GT1) n = 96, (b) HCV genotypes 1 and 3 (GT1/3) n = 72 and (c) HCV genotypes 1\u20136 (GT1-6) n = 216.",
            "startOffset": 21816,
            "title": "The selection of HCV sequences"
        },
        {
            "endOffset": 33402,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Of four epitopes associated with resolution in HCV genotype-1 infection, one (E2541NTRPPLGNW) was included in the HCV GT1 construct, whilst NS5B2629KSKKTPMGF is contained in the HCV GT1/3a and HCV GT1-6 constructs (but differs by one AA; NS5B2629TSKKTPMGF).",
            "startOffset": 33145,
            "title": "Identifying proteasomal cleavage sites, T- and B-cell epitopes within conserved immunogens"
        },
        {
            "endOffset": 40684,
            "parents": [],
            "secId": "s0090",
            "sentence": "It was therefore important to show that HCV conserved immunogens are processed and capable of priming immune responses in vivo.",
            "startOffset": 40557,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X17314871",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Annette",
                "initial": "A.",
                "last": "von Delft"
            },
            {
                "email": null,
                "first": "Timothy A.",
                "initial": "T.A.",
                "last": "Donnison"
            },
            {
                "email": null,
                "first": "Jos\u00e9",
                "initial": "J.",
                "last": "Louren\u00e7o"
            },
            {
                "email": null,
                "first": "Claire",
                "initial": "C.",
                "last": "Hutchings"
            },
            {
                "email": null,
                "first": "Caitlin E.",
                "initial": "C.E.",
                "last": "Mullarkey"
            },
            {
                "email": null,
                "first": "Anthony",
                "initial": "A.",
                "last": "Brown"
            },
            {
                "email": null,
                "first": "Oliver G.",
                "initial": "O.G.",
                "last": "Pybus"
            },
            {
                "email": null,
                "first": "Paul",
                "initial": "P.",
                "last": "Klenerman"
            },
            {
                "email": null,
                "first": "Senthil",
                "initial": "S.",
                "last": "Chinnakannan"
            },
            {
                "email": "ellie.barnes@ndm.ox.ac.uk",
                "first": "Eleanor",
                "initial": "E.",
                "last": "Barnes"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.10.079",
        "firstpage": "313",
        "issn": "0264410X",
        "keywords": [
            "Conserved segments",
            "Cross-reactivity",
            "HCV vaccine",
            "Simian adenovirus",
            "T cell"
        ],
        "lastpage": "321",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes"
    }
}